Results 21 to 30 of about 1,772,507 (392)

Lessons Learned and Future Perspectives for Rotavirus Vaccines Switch in the World Health Organization, Regional Office for Africa

Vaccines, 2023
Background: Following the World Health Organization (WHO) recommendation, 38/47 countries have introduced rotavirus vaccines into the program of immunization in the WHO Regional Office for Africa (WHO/AFRO).
I. Mandomando, Augusto Messa, J. Biey, Gilson Paluku, Mutale Mumba, J. Mwenda   +5 more
semanticscholar   +1 more source

Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries

Human Vaccines & Immunotherapeutics, 2022
Vaccine impact models against rotavirus disease (RD) and pneumococcal disease (PD) in low- and middle-income countries assume vaccine coverage based on other vaccines.
Alen Marijam, Lode Schuerman, Patricia Izurieta, Priya Pereira, Désirée Van Oorschot, Shailesh Mehta, Martin OC Ota, Baudouin Standaert   +7 more
doaj   +1 more source

The respiratory syncytial virus (RSV) prefusion F‐protein functional antibody repertoire in adult healthy donors

EMBO Molecular Medicine, 2021
Respiratory syncytial virus (RSV) is the leading cause of death from lower respiratory tract infection in infants and children, and is responsible for considerable morbidity and mortality in older adults. Vaccines for pregnant women and elderly which are
Emanuele Andreano, Ida Paciello, Monia Bardelli, Simona Tavarini, Chiara Sammicheli, Elisabetta Frigimelica, Silvia Guidotti, Giulia Torricelli, Marco Biancucci, Ugo D’Oro, Sumana Chandramouli, Matthew J Bottomley, Rino Rappuoli, Oretta Finco, Francesca Buricchi   +14 more
doaj   +1 more source

Acknowledgement to Reviewers of Vaccines in 2016

Vaccines, 2017
The editors of Vaccines would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2016.[...]
Vaccines Editorial Office
doaj   +1 more source

Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen

npj Vaccines, 2023
Seasonal influenza vaccines must be updated annually and suboptimally protect against strains mismatched to the selected vaccine strains. We previously developed a subunit vaccine antigen consisting of a stabilized trimeric influenza A group 1 ...
Maarten Swart, Harmjan Kuipers, Fin Milder, Mandy Jongeneelen, Tina Ritschel, Jeroen Tolboom, Leacky Muchene, Joan van der Lubbe, Ana Izquierdo Gil, Daniel Veldman, Jeroen Huizingh, Johan Verspuij, Sonja Schmit-Tillemans, Sven Blokland, Martijn de Man, Ramon Roozendaal, Christopher B. Fox, Hanneke Schuitemaker, Martinus Capelle, Johannes P. M. Langedijk, Roland Zahn, Boerries Brandenburg   +21 more
doaj   +1 more source

The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review

Human Vaccines & Immunotherapeutics, 2022
With the relatively rapid development of the COVID-19 pandemic, vaccine development has become crucial for limiting disease transmission. The accelerated growth in the approved COVID-19 vaccines has sparked concerns about their efficacies which have been
Ibrahim Mohammed, Areej Nauman, Pradipta Paul, Sanjith Ganesan, Kuan-Han Chen, S. Jalil, Shahd Jaouni, H. Kawas, Wafa Khan, Ahamed Lazim Vattoth, Y. Al-Hashimi, Ahmed Fares, Rached Zeghlache, Dalia Zakaria   +13 more
semanticscholar   +1 more source

Influenza and memory T cells : how to awake the force [PDF]

, 2016
Annual influenza vaccination is an effective way to prevent human influenza. Current vaccines are mainly focused on eliciting a strain-matched humoral immune response, requiring yearly updates, and do not provide protection for all vaccinated individuals.
Glezen, Hartshorn, Hufford, Jin, Jordan, Luo, Mosmann, Razvi, Topham, Topham, Topham, Von Andrian, Wijburg   +12 more
core   +3 more sources

Acknowledgement to Reviewers of Vaccines in 2014

Vaccines, 2015
The editors of Vaccines would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2014:[...]
Vaccines Editorial Office
doaj   +1 more source

Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment [PDF]

, 2014
There is an urgent need for rapid methods to develop vaccines in response to emerging viral pathogens. Whole inactivated virus (WIV) vaccines represent an ideal strategy for this purpose; however, a universal method for producing safe and immunogenic ...
Achilefu, Samuel, Chen, Alexander, Donthi, Nisha, Hsieh, Wen-Han, Hung, Chien-Fu, Knoff, Jayne, La, Victor, Li, Yen-Der, Tsen, Kong-Thon, Tsen, Shaw-Wei David, Wu, Tzyy-Choou   +10 more
core   +2 more sources

Nanomaterial Delivery Systems for mRNA Vaccines

Vaccines, 2021
The recent success of mRNA vaccines in SARS-CoV-2 clinical trials is in part due to the development of lipid nanoparticle delivery systems that not only efficiently express the mRNA-encoded immunogen after intramuscular injection, but also play roles as ...
M. Buschmann, Manuel J. Carrasco, Suman Alishetty, M. Paige, M. Alameh, D. Weissman   +5 more
semanticscholar   +1 more source